Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A retrospective cohort study noted that patients weighing greater than 150 kg tended to receive lower median doses of enoxaparin (Lovenox—sanofi–aventis) compared with patients who weighed less; also, obese patients who received standard enoxaparin dosing were at an increased risk of bleeding.

Related Articles

The Differences in Blood Levels of Lipids, Adipokines, and Proinflammatory Cytokines Among Normal, Overweight, and Obese Korean Women
The Endocrinologist, 11/16/09    Relevance Score: 91%%

Weight Loss Associated with Exercise Training Restores Ventilatory Efficiency in Obese Children
International Journal of Sports Medicine, 10/30/09    Relevance Score: 90%%

Body Perception and Satisfaction in Obese, Severely Obese, and Normal Weight Female Patients
Obesity, 11/17/09    Relevance Score: 89%%

Managing chronic oedema in the morbidly obese patient
British Journal of Nursing, 10/14/09    Relevance Score: 89%%

Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents
Metabolism-Clinical and Experimental, 10/09/09    Relevance Score: 89%%

Today in Dosing...keeping you current

Drug-Drug Interaction Between Itraconazole and the Protease Inhibitor Lopinavir/Ritonavir
Annals of Pharmacotherapy, 11/25/09

Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin
Central European Journal of Medicine, 11/24/09

Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients
Journal of Anesthesia, 11/24/09

Today in Stomach/GI...keeping you current

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address